William W Kwok Selected Research

Immunodominant Epitopes

1/2018	A Novel Approach of Identifying Immunodominant Self and Viral Antigen Cross-Reactive T Cells and Defining the Epitopes They Recognize.
8/2013	CD4+ T cells recognize unique and conserved 2009 H1N1 influenza hemagglutinin epitopes after natural infection and vaccination.
9/2010	Allergen-specific naïve and memory CD4+ T cells exhibit functional and phenotypic differences between individuals with or without allergy.
1/2002	Identification of type II collagen peptide 261-273-specific T cell clones in a patient with relapsing polychondritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

William W Kwok Research Topics

Disease

29	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2021 - 11/2003
20	Human Influenza (Influenza) 11/2021 - 09/2002
16	Infections 01/2021 - 11/2007
15	Neoplasms (Cancer) 01/2021 - 09/2002
9	Hypersensitivity (Allergy) 01/2019 - 09/2010
7	Rheumatoid Arthritis 12/2021 - 10/2010
7	Melanoma (Melanoma, Malignant) 01/2021 - 09/2002
6	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 11/2003
4	COVID-19 01/2022 - 11/2020
4	Celiac Disease (Celiac Sprue) 01/2021 - 08/2006
4	Asthma (Bronchial Asthma) 01/2020 - 12/2015
4	Disease Progression 01/2019 - 10/2002
4	Lyme Disease (Disease, Lyme) 04/2008 - 04/2006
3	Inflammation (Inflammations) 01/2022 - 03/2014
3	Multiple Sclerosis 11/2020 - 07/2011
3	Communicable Diseases (Infectious Diseases) 11/2020 - 01/2003
3	Testicular Neoplasms (Testicular Cancer) 01/2018 - 05/2004
3	Peanut Hypersensitivity (Peanut Allergy) 01/2018 - 05/2011
3	Seasonal Allergic Rhinitis (Hay Fever) 04/2014 - 02/2012
3	Arthritis (Polyarthritis) 04/2008 - 04/2006
2	Vasculitis (Vasculitides) 01/2022 - 01/2020
2	Blast Crisis (Blast Phase) 01/2021 - 11/2020
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 11/2020
2	Yellow Fever 01/2020 - 12/2013
2	Allergic Rhinitis 01/2019 - 01/2018
2	Tuberculosis (Tuberculoses) 05/2015 - 05/2012
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2014 - 09/2002
2	Viremia 02/2010 - 10/2003
1	Atopic Dermatitis (Atopic Eczema) 01/2022
1	Retinoblastoma (Glioblastoma, Retinal) 10/2019
1	Skin Neoplasms (Skin Cancer) 10/2019
1	Merkel Cell Carcinoma 10/2019
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 10/2019
1	Atherosclerosis 11/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2018
1	Breast Neoplasms (Breast Cancer) 01/2018

Drug/Important Bio-Agent (IBA)

41	Peptides (Polypeptides)IBA 01/2022 - 01/2002
32	AntigensIBA 12/2021 - 09/2002
31	EpitopesIBA 01/2020 - 09/2002
18	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2003
13	AutoantigensIBA 01/2020 - 11/2003
10	AllergensIBA 01/2020 - 09/2010
9	HLA-DR Antigens (HLA-DR)IBA 12/2018 - 04/2006
8	Insulin (Novolin)FDA Link 01/2020 - 11/2005
7	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2021 - 08/2006
6	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2021 - 08/2004
6	CytokinesIBA 11/2021 - 04/2010
5	VaccinesIBA 10/2019 - 07/2003
5	Hemagglutinins (Hemagglutinin)IBA 01/2019 - 11/2005
4	NucleoproteinsIBA 01/2022 - 09/2003
4	HLA-DQA1 antigen (HLA DQA1)IBA 11/2020 - 02/2006
4	Amino Acids FDA Link 11/2020 - 01/2017
4	Antiviral Agents (Antivirals)IBA 01/2020 - 05/2007
4	ProinsulinIBA 01/2019 - 11/2005
4	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2018 - 05/2004
4	Immunodominant EpitopesIBA 01/2018 - 01/2002
4	Tetanus ToxinIBA 04/2010 - 09/2005
4	Anti-Bacterial Agents (Antibiotics)IBA 04/2008 - 04/2006
3	HLA-DQ Antigens (HLA-DQ)IBA 11/2020 - 01/2017
3	Indicators and Reagents (Reagents)IBA 01/2020 - 10/2002
3	HLA-DQ8 antigenIBA 01/2019 - 08/2006
3	HLA-DRB1 Chains (HLA DRB1)IBA 01/2019 - 10/2010
3	OspA proteinIBA 01/2008 - 04/2006
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022 - 01/2020
2	Immunoglobulin G (IgG)IBA 11/2021 - 12/2015
2	Interleukin-2 (IL2)IBA 01/2021 - 10/2003
2	Glutens (Glutelin)IBA 01/2021 - 08/2006
2	HLA-DRB1*04:01 antigenIBA 10/2019 - 11/2007
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2019 - 11/2018
2	HLA-DRB3 Chains (HLA DRB3)IBA 01/2019 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 08/2011
2	AutoantibodiesIBA 01/2019 - 05/2002
2	Immunoglobulin E (IgE)IBA 01/2018 - 12/2015
2	hypoxanthine arabinoside (ara-H)IBA 01/2018 - 05/2011
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2018 - 10/2009
2	Interleukin-10 (Interleukin 10)IBA 05/2015 - 09/2010
2	Monophenol Monooxygenase (Tyrosinase)IBA 01/2013 - 05/2004
2	Interleukin-4 (Interleukin 4)IBA 05/2011 - 09/2010
2	Viral AntigensIBA 06/2010 - 09/2003
2	MART-1 AntigenIBA 10/2009 - 11/2006
1	Myeloblastin (Proteinase 3)IBA 01/2022
1	HLA-DPB1 antigen (HLA DPB1)IBA 01/2022
1	Fibronectins (Fibronectin)IBA 01/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	serum P-component (CIt)IBA 12/2021
1	TenascinIBA 12/2021
1	HLA-DR15 antigenIBA 11/2020
1	Peroxidase (Myeloperoxidase)IBA 01/2020
1	CitrullineIBA 01/2020
1	Oncogene Proteins (Oncogene Protein)IBA 10/2019
1	insulin B (9-23)IBA 01/2019
1	GliadinIBA 01/2019
1	Apolipoproteins B (ApoB)IBA 11/2018
1	Transcription Factors (Transcription Factor)IBA 11/2018
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 11/2018

Therapy/Procedure

10	Therapeutics 01/2021 - 11/2007
10	Immunotherapy 01/2019 - 01/2003
1	Drug Therapy (Chemotherapy) 01/2021
1	Induction Chemotherapy 11/2020
1	Transplantation 01/2018